Secular Trends in Patent Ductus Arteriosus Management in Infants Born Preterm in the National Institute of Child Health and Human Development Neonatal Research Network

Dinushan C Kaluarachchi,Matthew A Rysavy,Benjamin A Carper,Valerie Y Chock,Matthew M Laughon,Carl H Backes,Tarah T Colaizy,Edward F Bell,Patrick J McNamara

DOI: https://doi.org/10.1016/j.jpeds.2023.113877

Abstract:We evaluated changes in patent ductus arteriosus (PDA) diagnosis and treatment from 2012 through 2021 in a network of US academic hospitals. PDA treatment decreased among infants born at 26-28 weeks but not among infants born at 22-25 weeks. Rates of indomethacin use and PDA ligation decreased while acetaminophen use and transcatheter PDA closure increased.